Zobrazeno 1 - 6
of 6
pro vyhledávání: '"J O, Buchanan"'
Publikováno v:
Cardiovascular Drugs and Therapy. 5:763-768
Encainide is a class 1C antiarrhythmic agent that is indicated for the treatment of life-threatening arrhythmias, such as sustained ventricular tachycardia. Furthermore, encainide possesses a moderate degree of antiserotonin activity, which was quant
Autor:
N A, Meanwell, M J, Rosenfeld, A K, Trehan, J J, Wright, C L, Brassard, J O, Buchanan, M E, Federici, J S, Fleming, M, Gamberdella, K S, Hartl
Publikováno v:
Drug design and discovery. 11(1)
2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid, 1, has been described as a non-prostanoid PGI2 mimetic that demonstrates anti-thrombotic properties of long duration in animal models of thrombosis. The effects of substitution and modificat
Autor:
N A, Meanwell, M J, Rosenfeld, A K, Trehan, J J, Wright, C L, Brassard, J O, Buchanan, M E, Federici, J S, Fleming, M, Gamberdella, G B, Zavoico
Publikováno v:
Journal of medicinal chemistry. 35(19)
4,5-Diphenyl-2-oxazolenonanoic acid (18b) was synthesized and found to inhibit ADP-induced aggregation of human platelets with an IC50 of 2.5 microM. Acid 18b displaced [3H]iloprost from human platelet membranes in a concentration-dependent fashion,
Publikováno v:
Oral Presentations.
Prostacyclin and thromboxane A2, two of the physiologically most important end products of arachidonic acid metabolism, represent a basic control system which modulates platelet function. Decreased vascular prostacyclin is believed to play a role in
Report regarding experiments made to determine the fallout-radiation protection offered by five typical residential structures located at the Nevada Test Site.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::683bca87b0066a7d4c1834a22039aedb
https://doi.org/10.2172/4276019
https://doi.org/10.2172/4276019
Publikováno v:
Physical Review. 76:890-891